about
Four Principles to Consider Before Advising Women on Screening MammographyValue of screening endoscopy in evaluation of esophageal, gastric and colon cancersShould patients with autosomal dominant polycystic kidney disease be screened for cerebral aneurysms?The American College Of Radiology Imaging Network--clinical trials of diagnostic imaging and image-guided treatment.The ethics of how to manage incidental findings.The National Lung Screening Trial: overview and study design.Trends in CT colonography.Evaluating randomized trials of screening.Lung cancer screening with CTScreening and management of depression for adults with chronic diseases: an evidence-based analysisThe use of CT for screening: a national survey of radiologists' activities and attitudesScreening in the dark: ethical considerations of providing screening tests to individuals when evidence is insufficient to support screening populationsLong-term effect of population screening for diabetes on cardiovascular morbidity, self-rated health, and health behavior.Update in screening of lung cancer.Progressive multifocal leukoencephalopathy and multiple sclerosis: lessons from natalizumab.Computed tomography screening for lung cancer: review of screening principles and update on current status.What is the point: will screening mammography save my life?Effect of screening for Type 2 diabetes on population-level self-rated health outcomes and measures of cardiovascular risk: 13-year follow-up of the Ely cohort.Patient experiences of depression and anxiety with chronic disease: a systematic review and qualitative meta-synthesis.Depression screening in primary care: why the Canadian task force on preventive health care did the right thing.Considerations in the design of randomized trials to screen for type 2 diabetes.Predictors of malignancy in pancreatic head mass: a prospective study.Is there evidence to support serum antinuclear antibodies testing in women with recurrent implantation failure undergoing in vitro fertilization?Consistency and sources of divergence in recommendations on screening with questionnaires for presently experienced health problems or symptoms: a comparison of recommendations from the Canadian Task Force on Preventive Health Care, UK National ScreThe management of multiple sclerosis by reference centers in south of Italy: a 2011 survey on health demands and needs in Campania region.Breast imaging. A look at current and future technologies.Shared medical decision-making: a new paradigm for behavioral medicine--1997 presidential address.Misinterpretation of the chest x ray as a factor in the delayed diagnosis of lung cancer.Effect of population screening for type 2 diabetes on mortality: long-term follow-up of the Ely cohort.Reduced mammographic screening may explain declines in breast carcinoma in older women.Diagnostic and treatment decisions in US healthcare.When and how should patients with multiple endocrine neoplasia type 1 be screened for thymic and bronchial carcinoid tumours?Overdiagnosis: An underrecognized cause of confusion and harm in cancer screening.
P2860
Q26779927-ECA9DC0A-1357-41A0-BBFB-8F78A689E6A0Q26781528-419DFCBF-1916-4F8E-BC93-D04981AAAF55Q26862813-C0DAE568-DCC6-470A-A889-791BFCAA00EBQ30424839-FF21BB7D-6B82-483A-9732-18196C445037Q33728442-F3FDC6CE-950E-40A4-94B7-0AEE6C1EE929Q33736528-66E62139-5B6E-4E42-BFE8-02B69ABBAD84Q34371985-78E77DD8-A477-4E35-ADB4-F63086A522CFQ34752656-9B8E3357-FC1F-4A26-9E3D-739A6C9CE5B9Q35018681-28276638-7AA0-481D-A9AF-E99AFF70DA9FQ35019551-5C16ACD1-60B7-4761-918B-D17AF34C3BBDQ35032899-7B3E746F-162D-4A72-9387-A9FDC77167E3Q35046772-28EB5DED-A667-4720-A787-CED4D4364550Q35205975-59807B80-8D48-4BBA-A77D-781F3315B3A0Q36305897-C6DC1A91-3745-4B4F-8586-8FAC103D04A9Q36458748-22FF69D1-4DB9-47FE-BC7F-546DC13FB6DCQ36973577-CE2481A7-6EDE-4F22-A5C2-BDEC7D047EA3Q37161262-671F057A-CA91-4CE6-B506-627EB46AEAC4Q37271306-82422C4C-3841-4179-A052-E4C00F533D96Q37280668-4C1F9A86-AA91-4970-ADB5-B55633C6B511Q38170639-F658386A-7645-4240-BC2D-49CE237B82ABQ38181450-B952116E-4C7E-41BB-9704-AB1641CADC43Q39091616-1F750389-34AB-43D7-8790-598F395A1320Q39207073-D0BC21A2-8077-46EA-8CC5-D8FD0B80919DQ40090385-C46A4706-8AAE-4720-B068-D5D78896EF35Q40462990-7C10A2F7-06EC-4F03-8898-F495E8111C9BQ40834866-56B5DDB2-7E45-4A95-A926-074FAC768C5EQ42652599-1327D258-A95B-430E-BB33-C4479B51483FQ43064902-631FA286-AB2E-4A4D-B282-410082FB2E28Q44642648-F83DA2F5-D1C2-4B3E-B49D-7199DD268FB3Q46048556-DA7897BF-2E21-41C5-B39E-3D2DA072E5DBQ46758097-01CD8140-12B3-40DD-9BF7-05ACEEA64A2FQ47913061-BD6E0F95-9C1B-4098-8963-0BF83380E7EFQ52924849-69FCD3BE-3904-4780-A797-26151F022610
P2860
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Screening for disease.
@en
type
label
Screening for disease.
@en
prefLabel
Screening for disease.
@en
P1476
Screening for disease.
@en
P2093
P356
10.2214/AJR.168.1.8976910
P407
P577
1997-01-01T00:00:00Z